Event Title

GH3 -- Comparing different treatment modalities for T1/T2 NSLC at a Regional Hospital

Location

URC Greatroom

Start Date

8-4-2022 10:30 AM

End Date

8-4-2022 12:15 PM

Description

In the United States lung cancer remains one of the leading causes of cancer death among men and women and approximately 85% of all diagnoses are non-small cell lung cancer (NSCLC). The standard of care for stage I and II NSCLC has remained surgical resection in the form of lobectomy since a prospective trial by Ginsberg and Rubinstein in 1995(1). Starting in the 1990s video-assisted thoracic surgery (VATS) has been widely used as treatment for NSCLC and has been shown to have better perioperative outcomes compared to conventional open thoracotomies (2). In recent years VATS has been replaced by robotic-assisted thoracic surgery (RATS) by most surgeons for lung cancer resection. Still there remains no clear conclusion if RATS or VATS is better for long term outcomes of patients. In this study the aim was to compare post-operative outcomes and long-term outcomes between RATS and VATS for NSCLC. Our study analyzed the outcomes of 386 patients with T1/T2 NSLC treated at Greenville Memorial Hospital from 2007-2015 that underwent surgical treatment. At the time of this conference, we will have analysis for treatment outcomes including 1-, 3-, and 5-, 7- year survival and recurrence rates. We will compare our results to the current literature on NSCLC treatment in order to further optimize treatment outcomes for patients. 1. Ginsberg, R. J., Rubinstein, L. V., & Lung Cancer Study Group. (1995). Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. The Annals of thoracic surgery, 60(3), 615-623 2. Ma, J., Li, X., Zhao, S., Wang, J., Zhang, W., & Sun, G. (2021). Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis. BMC cancer, 21(1), 1-16.

This document is currently not available here.

Share

COinS
 
Apr 8th, 10:30 AM Apr 8th, 12:15 PM

GH3 -- Comparing different treatment modalities for T1/T2 NSLC at a Regional Hospital

URC Greatroom

In the United States lung cancer remains one of the leading causes of cancer death among men and women and approximately 85% of all diagnoses are non-small cell lung cancer (NSCLC). The standard of care for stage I and II NSCLC has remained surgical resection in the form of lobectomy since a prospective trial by Ginsberg and Rubinstein in 1995(1). Starting in the 1990s video-assisted thoracic surgery (VATS) has been widely used as treatment for NSCLC and has been shown to have better perioperative outcomes compared to conventional open thoracotomies (2). In recent years VATS has been replaced by robotic-assisted thoracic surgery (RATS) by most surgeons for lung cancer resection. Still there remains no clear conclusion if RATS or VATS is better for long term outcomes of patients. In this study the aim was to compare post-operative outcomes and long-term outcomes between RATS and VATS for NSCLC. Our study analyzed the outcomes of 386 patients with T1/T2 NSLC treated at Greenville Memorial Hospital from 2007-2015 that underwent surgical treatment. At the time of this conference, we will have analysis for treatment outcomes including 1-, 3-, and 5-, 7- year survival and recurrence rates. We will compare our results to the current literature on NSCLC treatment in order to further optimize treatment outcomes for patients. 1. Ginsberg, R. J., Rubinstein, L. V., & Lung Cancer Study Group. (1995). Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. The Annals of thoracic surgery, 60(3), 615-623 2. Ma, J., Li, X., Zhao, S., Wang, J., Zhang, W., & Sun, G. (2021). Robot-assisted thoracic surgery versus video-assisted thoracic surgery for lung lobectomy or segmentectomy in patients with non-small cell lung cancer: a meta-analysis. BMC cancer, 21(1), 1-16.